|
1
|
Ohuma EO, Moller AB, Bradley E, Chakwera
S, Hussain-Alkhateeb L, Lewin A, Okwaraji YB, Mahanani WR,
Johansson EW, Lavin T, et al: National, regional, and global
estimates of preterm birth in 2020, with trends from 2010: A
systematic analysis. Lancet. 402:1261–1271. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saigal S and Doyle LW: An overview of
mortality and sequelae of preterm birth from infancy to adulthood.
Lancet. 371:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldenberg RL, Culhane JF, Iams JD and
Romero R: Epidemiology and causes of preterm birth. Lancet.
371:75–84. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Romero R, Gomez-Lopez N, Winters AD, Jung
E, Shaman M, Bieda J, Panaitescu B, Pacora P, Erez O, Greenberg JM,
et al: Evidence that intra-amniotic infections are often the result
of an ascending invasion-a molecular microbiological study. J
Perinat Med. 47:915–931. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witkin SS: The vaginal microbiome, vaginal
anti-microbial defence mechanisms and the clinical challenge of
reducing infection-related preterm birth. BJOG. 122:213–218. 2015.
View Article : Google Scholar
|
|
6
|
Fox C and Eichelberger K: Maternal
microbiome and pregnancy outcomes. Fertil Steril. 104:1358–1363.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tabatabaei N, Eren AM, Barreiro LB, Yotova
V, Dumaine A, Allard C and Fraser WD: Vaginal microbiome in early
pregnancy and subsequent risk of spontaneous preterm birth: A
case-control study. BJOG. 126:349–358. 2019. View Article : Google Scholar
|
|
8
|
Liu L, Yin T, Zhang X, Sun L and Yin Y:
Temporal and spatial variation of the human placental microbiota
during pregnancy. Am J Reprod Immunol. 92:e700232024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Conde-Agudelo A, Papageorghiou AT, Kennedy
SH and Villar J: Novel biomarkers for the prediction of the
spontaneous preterm birth phenotype: A systematic review and
meta-analysis. BJOG. 118:1042–1054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meertens LJE, van Montfort P, Scheepers
HCJ, van Kuijk SMJ, Aardenburg R, Langenveld J, van Dooren IMA,
Zwaan IM, Spaanderman MEA and Smits LJM: Prediction models for the
risk of spontaneous preterm birth based on maternal
characteristics: A systematic review and independent external
validation. Acta Obstet Gynecol Scand. 97:907–920. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hickey RJ, Zhou X, Pierson JD, Ravel J and
Forney LJ: Understanding vaginal microbiome complexity from an
ecological perspective. Transl Res. 160:267–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Happel AU, Kullin B, Gamieldien H, Wentzel
N, Zauchenberger CZ, Jaspan HB, Dabee S, Barnabas SL, Jaumdally SZ,
Dietrich J, et al: Exploring potential of vaginal Lactobacillus
isolates from South African women for enhancing treatment for
bacterial vaginosis. PLoS Pathog. 16:e10085592020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giannella L, Grelloni C, Quintili D,
Fiorelli A, Montironi R, Alia S, Delli Carpini G, Di Giuseppe J,
Vignini A and Ciavattini A: Microbiome changes in pregnancy
disorders. Antioxidants (Basel). 12:4632023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bayar E, Bennett PR, Chan D, Sykes L and
MacIntyre DA: The pregnancy microbiome and preterm birth. Semin
Immunopathol. 42:487–499. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bachmann NL, Rockett RJ, Timms VJ and
Sintchenko V: Advances in clinical sample preparation for
identification and characterization of bacterial pathogens using
metagenomics. Front Public Health. 6:3632018. View Article : Google Scholar
|
|
16
|
Sroka-Oleksiak A, Gosiewski T, Pabian W,
Gurgul A, Kapusta P, Ludwig-Słomczyńska AH, Wołkow PP and
Brzychczy-Włoch M: Next-generation sequencing as a tool to detect
vaginal microbiota disturbances during pregnancy. Microorganisms.
8:18132020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Linhares IM, Summers PR, Larsen B, Giraldo
PC and Witkin SS: Contemporary perspectives on vaginal pH and
lactobacilli. Am J Obstet Gynecol. 204:120.e1–e5. 2011. View Article : Google Scholar
|
|
18
|
Ravel J, Gajer P, Abdo Z, Schneider GM,
Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO,
et al: Vaginal microbiome of reproductive-age women. Proc Natl Acad
Sci USA. 108(Suppl 1): S4680–S4687. 2011. View Article : Google Scholar
|
|
19
|
Blostein F, Gelaye B, Sanchez SE, Williams
MA and Foxman B: Vaginal microbiome diversity and preterm birth:
Results of a nested case-control study in Peru. Ann Epidemiol.
41:28–34. 2020. View Article : Google Scholar
|
|
20
|
Stennett CA, Dyer TV, He X, Robinson CK,
Ravel J, Ghanem KG and Brotman RM: A cross-sectional pilot study of
birth mode and vaginal microbiota in reproductive-age women. PLoS
One. 15:e02285742020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chaban B, Links MG, Jayaprakash TP, Wagner
EC, Bourque DK, Lohn Z, Albert AY, van Schalkwyk J, Reid G,
Hemmingsen SM, et al: Characterization of the vaginal microbiota of
healthy Canadian women through the menstrual cycle. Microbiome.
2:232014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roy EJ and Mackay R: The concentration of
oestrogens in blood during pregnancy. J Obstet Gynaecol Br Emp.
69:13–17. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma B, Forney LJ and Ravel J: Vaginal
microbiome: Rethinking health and disease. Annu Rev Microbiol.
66:371–389. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van de Wijgert J and Verwijs MC:
Lactobacilli-containing vaginal probiotics to cure or prevent
bacterial or fungal vaginal dysbiosis: A systematic review and
recommendations for future trial designs. BJOG. 127:287–299. 2020.
View Article : Google Scholar
|
|
25
|
Bhandari P, Tingley JP, Palmer DRJ, Abbott
DW and Hill JE: Characterization of an α-Glucosidase enzyme
conserved in gardnerella spp. isolated from the human vaginal
microbiome. J Bacteriol. 203:e00213212021. View Article : Google Scholar
|
|
26
|
Rosca AS, Castro J, Sousa LGV and Cerca N:
Gardnerella and vaginal health: The truth is out there. FEMS
Microbiol Rev. 44:73–105. 2020. View Article : Google Scholar
|
|
27
|
Tachedjian G, Aldunate M, Bradshaw CS and
Cone RA: The role of lactic acid production by probiotic
Lactobacillus species in vaginal health. Res Microbiol.
168:782–792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kaur H, Merchant M, Haque MM and Mande SS:
Crosstalk between female gonadal hormones and vaginal microbiota
across various phases of women's gynecological lifecycle. Front
Microbiol. 11:5512020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Anderson DJ, Marathe J and Pudney J: The
structure of the human vaginal stratum corneum and its role in
immune defense. Am J Reprod Immunol. 71:618–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen J, Song N, Williams CJ, Brown CJ, Yan
Z, Xu C and Forney LJ: Effects of low dose estrogen therapy on the
vaginal microbiomes of women with atrophic vaginitis. Sci Rep.
6:243802016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cauci S, Driussi S, De Santo D,
Penacchioni P, Iannicelli T, Lanzafame P, De Seta F, Quadrifoglio
F, de Aloysio D and Guaschino S: Prevalence of bacterial vaginosis
and vaginal flora changes in peri- and postmenopausal women. J Clin
Microbiol. 40:2147–2152. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brooks JP, Edwards DJ, Blithe DL, Fettweis
JM, Serrano MG, Sheth NU, Strauss JF III, Buck GA and Jefferson KK:
Effects of combined oral contraceptives, depot medroxyprogesterone
acetate and the levonorgestrel-releasing intrauterine system on the
vaginal microbiome. Contraception. 95:405–413. 2017. View Article : Google Scholar
|
|
33
|
Bradshaw CS, Vodstrcil LA, Hocking JS, Law
M, Pirotta M, Garland SM, De Guingand D, Morton AN and Fairley CK:
Recurrence of bacterial vaginosis is significantly associated with
posttreatment sexual activities and hormonal contraceptive use.
Clin Infect Dis. 56:777–786. 2013. View Article : Google Scholar
|
|
34
|
Garcia-Garcia RM, Arias-Álvarez M,
Jordán-Rodríguez D, Rebollar PG, Lorenzo PL, Herranz C and
Rodríguez JM: Female reproduction and the microbiota in mammals:
Where are we? Theriogenology. 194:144–153. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fettweis JM, Serrano MG, Brooks JP,
Edwards DJ, Girerd PH, Parikh HI, Huang B, Arodz TJ, Edupuganti L,
Glascock AL, et al: The vaginal microbiome and preterm birth. Nat
Med. 25:1012–1021. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Serrano MG, Parikh HI, Brooks JP, Edwards
DJ, Arodz TJ, Edupuganti L, Huang B, Girerd PH, Bokhari YA, Bradley
SP, et al: Racioethnic diversity in the dynamics of the vaginal
microbiome during pregnancy. Nat Med. 25:1001–1011. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
MacIntyre DA, Chandiramani M, Lee YS,
Kindinger L, Smith A, Angelopoulos N, Lehne B, Arulkumaran S, Brown
R, Teoh TG, et al: The vaginal microbiome during pregnancy and the
postpartum period in a European population. Sci Rep. 5:89882015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang X, Zhai Q, Wang J, Ma X, Xing B, Fan
H, Gao Z, Zhao F and Liu W: Variation of the vaginal microbiome
during and after pregnancy in Chinese women. Genomics Proteomics
Bioinformatics. 20:322–333. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shachar BZ, Mayo JA, Lyell DJ, Baer RJ,
Jeliffe-Pawlowski LL, Stevenson DK and Shaw GM: Interpregnancy
interval after live birth or pregnancy termination and estimated
risk of preterm birth: A retrospective cohort study. BJOG.
123:2009–2017. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McKinney D, House M, Chen A, Muglia L and
DeFranco E: The influence of interpregnancy interval on infant
mortality. Am J Obstet Gynecol. 216:316.e1–316.e9. 2017. View Article : Google Scholar
|
|
41
|
Kangatharan C, Labram S and Bhattacharya
S: Interpregnancy interval following miscarriage and adverse
pregnancy outcomes: Systematic review and meta-analysis. Hum Reprod
Update. 23:221–231. 2017.
|
|
42
|
Bobitt JR and Ledger WJ: Unrecognized
amnionitis and prematurity: A preliminary report. J Reprod Med.
19:8–12. 1977.PubMed/NCBI
|
|
43
|
Andrews WW, Hauth JC, Goldenberg RL, Gomez
R, Romero R and Cassell GH: Amniotic fluid interleukin-6:
Correlation with upper genital tract microbial colonization and
gestational age in women delivered after spontaneous labor versus
indicated delivery. Am J Obstet Gynecol. 173:606–612. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Andrews WW, Goldenberg RL, Hauth JC,
Cliver SP, Conner M and Goepfert AR: Endometrial microbial
colonization and plasma cell endometritis after spontaneous or
indicated preterm versus term delivery. Am J Obstet Gynecol.
193:739–745. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hillier SL, Krohn MA, Cassen E, Easterling
TR, Rabe LK and Eschenbach DA: The role of bacterial vaginosis and
vaginal bacteria in amniotic fluid infection in women in preterm
labor with intact fetal membranes. Clin Infect Dis. 20(Suppl 2):
S276–S278. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leitich H and Kiss H: Asymptomatic
bacterial vaginosis and intermediate flora as risk factors for
adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol.
21:375–390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hay PE, Lamont RF, Taylor-Robinson D,
Morgan DJ, Ison C and Pearson J: Abnormal bacterial colonisation of
the genital tract and subsequent preterm delivery and late
miscarriage. BMJ. 308:295–298. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Leitich H, Bodner-Adler B, Brunbauer M,
Kaider A, Egarter C and Husslein P: Bacterial vaginosis as a risk
factor for preterm delivery: A meta-analysis. Am J Obstet Gynecol.
189:139–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Carey JC, Klebanoff MA, Hauth JC, Hillier
SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ,
et al: Metronidazole to prevent preterm delivery in pregnant women
with asymptomatic bacterial vaginosis. National institute of child
health and human development network of maternal-fetal medicine
units. N Engl J Med. 342:534–540. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Klebanoff MA, Carey JC, Hauth JC, Hillier
SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, et
al: Failure of metronidazole to prevent preterm delivery among
pregnant women with asymptomatic Trichomonas vaginalis infection. N
Engl J Med. 345:487–493. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Brocklehurst P, Hannah M and McDonald H:
Interventions for treating bacterial vaginosis in pregnancy.
Cochrane Database Syst Rev. Jan 20–2000.Epub ahead of print.
PubMed/NCBI
|
|
52
|
Guise JM, Mahon SM, Aickin M, Helfand M,
Peipert JF and Westhoff C: Screening for bacterial vaginosis in
pregnancy. Am J Prev Med. 20(Suppl 3): S62–S72. 2001. View Article : Google Scholar
|
|
53
|
Koumans EH, Markowitz LE and Hogan V; CDC
BV Working Group: Indications for therapy and treatment
recommendations for bacterial vaginosis in nonpregnant and pregnant
women: A synthesis of data. Clin Infect Dis. 35(Suppl 2):
S152–S172. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
54
|
Petrova MI, van den Broek M, Balzarini J,
Vanderleyden J and Lebeer S: Vaginal microbiota and its role in HIV
transmission and infection. FEMS Microbiol Rev. 37:762–792. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Peebles K, Velloza J, Balkus JE,
McClelland RS and Barnabas RV: High global burden and costs of
bacterial vaginosis: A systematic review and meta-analysis. Sex
Transm Dis. 46:304–311. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Onderdonk AB, Delaney ML and Fichorova RN:
The human microbiome during bacterial vaginosis. Clin Microbiol
Rev. 29:223–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang
Y, Li L, Nelson KE, Xia Y and Xiang C: Molecular analysis of the
diversity of vaginal microbiota associated with bacterial
vaginosis. BMC Genomics. 11:4882010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Muzny CA and Schwebke JR: Gardnerella
vaginalis: Still a prime suspect in the pathogenesis of bacterial
vaginosis. Curr Infect Dis Rep. 15:130–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Garcia EM, Serrano MG, Edupuganti L,
Edwards DJ, Buck GA and Jefferson KK: Sequence comparison of
vaginolysin from different gardnerella species. Pathogens.
10:862021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Vaneechoutte M, Guschin A, Van Simaey L,
Gansemans Y, Van Nieuwerburgh F and Cools P: Emended description of
Gardnerella vaginalis and description of Gardnerella leopoldii sp.
nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp.
nov., with delineation of 13 genomic species within the genus
Gardnerella. Int J Syst Evol Microbiol. 69:679–687. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ahmed A, Earl J, Retchless A, Hillier SL,
Rabe LK, Cherpes TL, Powell E, Janto B, Eutsey R, Hiller NL, et al:
Comparative genomic analyses of 17 clinical isolates of Gardnerella
vaginalis provide evidence of multiple genetically isolated clades
consistent with subspeciation into genovars. J Bacteriol.
194:3922–3937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Balashov SV, Mordechai E, Adelson ME and
Gygax SE: Identification, quantification and subtyping of
Gardnerella vaginalis in noncultured clinical vaginal samples by
quantitative PCR. J Med Microbiol. 63:162–175. 2014. View Article : Google Scholar
|
|
63
|
Georgijević A, Cjukić-Ivancević S and
Bujko M: Bacterial vaginosis. Epidemiology and risk factors. Srp
Arh Celok Lek. 128:29–33. 2000.In Serbian.
|
|
64
|
van de Wijgert JH, Borgdorff H, Verhelst
R, Crucitti T, Francis S, Verstraelen H and Jespers V: The vaginal
microbiota: what have we learned after a decade of molecular
characterization? PLoS One. 9:e1059982014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
France MT, Fu L, Rutt L, Yang H, Humphrys
MS, Narina S, Gajer PM, Ma B, Forney LJ and Ravel J: Insight into
the ecology of vaginal bacteria through integrative analyses of
metagenomic and metatranscriptomic data. Genome Biol. 23:662022.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Garcia EM, Kraskauskiene V, Koblinski JE
and Jefferson KK: Interaction of gardnerella vaginalis and
vaginolysin with the apical versus basolateral face of a
three-dimensional model of vaginal epithelium. Infect Immun.
87:e00646–18. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ragaliauskas T, Plečkaitytė M, Jankunec M,
Labanauskas L, Baranauskiene L and Valincius G: Inerolysin and
vaginolysin, the cytolysins implicated in vaginal dysbiosis,
differently impair molecular integrity of phospholipid membranes.
Sci Rep. 9:106062019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Jung HS, Ehlers MM, Lombaard H,
Redelinghuys MJ and Kock MM: Etiology of bacterial vaginosis and
polymicrobial biofilm formation. Crit Rev Microbiol. 43:651–667.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Swidsinski A, Dörffel Y, Loening-Baucke V,
Schilling J and Mendling W: Response of Gardnerella vaginalis
biofilm to 5 days of moxifloxacin treatment. FEMS Immunol Med
Microbiol. 61:41–46. 2011. View Article : Google Scholar
|
|
70
|
Castro J, Machado D and Cerca N: Unveiling
the role of Gardnerella vaginalis in polymicrobial Bacterial
Vaginosis biofilms: The impact of other vaginal pathogens living as
neighbors. ISME J. 13:1306–1317. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Jones HE, Harris KA, Azizia M, Bank L,
Carpenter B, Hartley JC, Klein N and Peebles D: Differing
prevalence and diversity of bacterial species in fetal membranes
from very preterm and term labor. PLoS One. 4:e82052009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Suff N, Karda R, Diaz JA, Ng J, Baruteau
J, Perocheau D, Tangney M, Taylor PW, Peebles D, Buckley SMK and
Waddington SN: Ascending vaginal infection using bioluminescent
bacteria evokes intrauterine inflammation, preterm birth, and
neonatal brain injury in pregnant mice. Am J Pathol. 188:2164–2176.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Randis TM, Gelber SE, Hooven TA, Abellar
RG, Akabas LH, Lewis EL, Walker LB, Byland LM, Nizet V and Ratner
AJ: Group B Streptococcus β-hemolysin/cytolysin breaches
maternal-fetal barriers to cause preterm birth and intrauterine
fetal demise in vivo. J Infect Dis. 210:265–273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Romero R, Hassan SS, Gajer P, Tarca AL,
Fadrosh DW, Bieda J, Chaemsaithong P, Miranda J, Chaiworapongsa T
and Ravel J: The vaginal microbiota of pregnant women who
subsequently have spontaneous preterm labor and delivery and those
with a normal delivery at term. Microbiome. 2:182014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nelson DB, Shin H, Wu J and
Dominguez-Bello MG: The gestational vaginal microbiome and
spontaneous preterm birth among Nulliparous African American Women.
Am J Perinatol. 33:887–893. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Stout MJ, Zhou Y, Wylie KM, Tarr PI,
Macones GA and Tuuli MG: Early pregnancy vaginal microbiome trends
and preterm birth. Am J Obstet Gynecol. 217:356.e1–356.e18. 2017.
View Article : Google Scholar
|
|
77
|
Kindinger LM, Bennett PR, Lee YS, Marchesi
JR, Smith A, Cacciatore S, Holmes E, Nicholson JK, Teoh TG and
MacIntyre DA: The interaction between vaginal microbiota, cervical
length, and vaginal progesterone treatment for preterm birth risk.
Microbiome. 5:62017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Petrova MI, Reid G, Vaneechoutte M and
Lebeer S: Lactobacillus iners: Friend or Foe? Trends Microbiol.
25:182–191. 2017. View Article : Google Scholar
|
|
79
|
Srinivasan S, Hoffman NG, Morgan MT,
Matsen FA, Fiedler TL, Hall RW, Ross FJ, McCoy CO, Bumgarner R,
Marrazzo JM and Fredricks DN: Bacterial communities in women with
bacterial vaginosis: High resolution phylogenetic analyses reveal
relationships of microbiota to clinical criteria. PLoS One.
7:e378182012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Santiago GL, Cools P, Verstraelen H, Trog
M, Missine G, El Aila N, Verhelst R, Tency I, Claeys G, Temmerman M
and Vaneechoutte M: Longitudinal study of the dynamics of vaginal
microflora during two consecutive menstrual cycles. PLoS One.
6:e281802011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Tamrakar R, Yamada T, Furuta I, Cho K,
Morikawa M, Yamada H, Sakuragi N and Minakami H: Association
between Lactobacillus species and bacterial vaginosis-related
bacteria, and bacterial vaginosis scores in pregnant Japanese
women. BMC Infect Dis. 7:1282007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shipitsyna E, Roos A, Datcu R, Hallén A,
Fredlund H, Jensen JS, Engstrand L and Unemo M: Composition of the
vaginal microbiota in women of reproductive age-sensitive and
specific molecular diagnosis of bacterial vaginosis is possible?
PLoS One. 8:e606702013. View Article : Google Scholar
|
|
83
|
Verstraelen H, Verhelst R, Claeys G, De
Backer E, Temmerman M and Vaneechoutte M: Longitudinal analysis of
the vaginal microflora in pregnancy suggests that L. crispatus
promotes the stability of the normal vaginal microflora and that L.
gasseri and/or L. iners are more conducive to the occurrence of
abnormal vaginal microflora. BMC Microbiol. 9:1162009. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Santiago GL, Tency I, Verstraelen H,
Verhelst R, Trog M, Temmerman M, Vancoillie L, Decat E, Cools P and
Vaneechoutte M: Longitudinal qPCR study of the dynamics of L.
crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis,
and P. bivia in the vagina. PLoS One. 7:e452812012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Macklaim JM, Fernandes AD, Di Bella JM,
Hammond JA, Reid G and Gloor GB: Comparative meta-RNA-seq of the
vaginal microbiota and differential expression by Lactobacillus
iners in health and dysbiosis. Microbiome. 1:122013. View Article : Google Scholar
|
|
86
|
Gajer P, Brotman RM, Bai G, Sakamoto J,
Schütte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, et al:
Temporal dynamics of the human vaginal microbiota. Sci Transl Med.
4:132ra522012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Petricevic L, Domig KJ, Nierscher FJ,
Sandhofer MJ, Fidesser M, Krondorfer I, Husslein P, Kneifel W and
Kiss H: Characterisation of the vaginal Lactobacillus microbiota
associated with preterm delivery. Sci Rep. 4:51362014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Baldwin EA, Walther-Antonio M, MacLean AM,
Gohl DM, Beckman KB, Chen J, White B, Creedon DJ and Chia N:
Persistent microbial dysbiosis in preterm premature rupture of
membranes from onset until delivery. PeerJ. 3:e13982015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Brown RG, Marchesi JR, Lee YS, Smith A,
Lehne B, Kindinger LM, Terzidou V, Holmes E, Nicholson JK, Bennett
PR and MacIntyre DA: Vaginal dysbiosis increases risk of preterm
fetal membrane rupture, neonatal sepsis and is exacerbated by
erythromycin. BMC Med. 16:92018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Brown RG, Al-Memar M, Marchesi JR, Lee YS,
Smith A, Chan D, Lewis H, Kindinger L, Terzidou V, Bourne T, et al:
Establishment of vaginal microbiota composition in early pregnancy
and its association with subsequent preterm prelabor rupture of the
fetal membranes. Transl Res. 207:30–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
DiGiulio DB, Callahan BJ, McMurdie PJ,
Costello EK, Lyell DJ, Robaczewska A, Sun CL, Goltsman DS, Wong RJ,
Shaw G, et al: Temporal and spatial variation of the human
microbiota during pregnancy. Proc Natl Acad Sci USA.
112:11060–11065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Callahan BJ, DiGiulio DB, Goltsman DSA,
Sun CL, Costello EK, Jeganathan P, Biggio JR, Wong RJ, Druzin ML,
Shaw GM, et al: Replication and refinement of a vaginal microbial
signature of preterm birth in two racially distinct cohorts of US
women. Proc Natl Acad Sci USA. 114:9966–9971. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Hyman RW, Fukushima M, Jiang H, Fung E,
Rand L, Johnson B, Vo KC, Caughey AB, Hilton JF, Davis RW and
Giudice LC: Diversity of the vaginal microbiome correlates with
preterm birth. Reprod Sci. 21:32–40. 2014. View Article : Google Scholar :
|
|
94
|
Elovitz MA, Gajer P, Riis V, Brown AG,
Humphrys MS, Holm JB and Ravel J: Cervicovaginal microbiota and
local immune response modulate the risk of spontaneous preterm
delivery. Nat Commun. 10:13052019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Sun S, Serrano MG, Fettweis JM, Basta P,
Rosen E, Ludwig K, Sorgen AA, Blakley IC, Wu MC, Dole N, et al:
Race, the vaginal microbiome, and spontaneous preterm birth.
mSystems. 7:e00017222022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Kumar M, Murugesan S, Singh P, Saadaoui M,
Elhag DA, Terranegra A, Kabeer BSA, Marr AK, Kino T, Brummaier T,
et al: Vaginal microbiota and cytokine levels predict preterm
delivery in Asian women. Front Cell Infect Microbiol.
11:6396652021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kindinger LM, MacIntyre DA, Lee YS,
Marchesi JR, Smith A, McDonald JA, Terzidou V, Cook JR, Lees C,
Israfil-Bayli F, et al: Relationship between vaginal microbial
dysbiosis, inflammation, and pregnancy outcomes in cervical
cerclage. Sci Transl Med. 8:350ra1022016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Green ES and Arck PC: Pathogenesis of
preterm birth: Bidirectional inflammation in mother and fetus.
Semin Immunopathol. 42:413–429. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wahid HH, Dorian CL, Chin PY, Hutchinson
MR, Rice KC, Olson DM, Moldenhauer LM and Robertson SA: Toll-Like
receptor 4 is an essential upstream regulator of on-time
parturition and perinatal viability in mice. Endocrinology.
156:3828–3841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Chin PY, Dorian CL, Hutchinson MR, Olson
DM, Rice KC, Moldenhauer LM and Robertson SA: Novel Toll-like
receptor-4 antagonist (+)-naloxone protects mice from
inflammation-induced preterm birth. Sci Rep. 6:361122016.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Deng W, Yuan J, Cha J, Sun X, Bartos A,
Yagita H, Hirota Y and Dey SK: Endothelial cells in the decidual
bed are potential therapeutic targets for preterm birth prevention.
Cell Rep. 27:1755–1768.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liassides C, Papadopoulos A, Siristatidis
C, Damoraki G, Liassidou A, Chrelias C, Kassanos D and
Giamarellos-Bourboulis EJ: Single nucleotide polymorphisms of
Toll-like receptor-4 and of autophagy-related gene 16 like-1 gene
for predisposition of premature delivery: A prospective study.
Medicine (Baltimore). 98:e173132019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Filipovich Y, Lu SJ, Akira S and Hirsch E:
The adaptor protein MyD88 is essential for E coli-induced preterm
delivery in mice. Am J Obstet Gynecol. 200:93.e1–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Montalbano AP, Hawgood S and Mendelson CR:
Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2
manifest delayed parturition and decreased expression of
inflammatory and contractile genes. Endocrinology. 154:483–498.
2013. View Article : Google Scholar :
|
|
105
|
Patni S, Wynen LP, Seager AL, Morgan G,
White JO and Thornton CA: Expression and activity of Toll-like
receptors 1-9 in the human term placenta and changes associated
with labor at term. Biol Reprod. 80:243–248. 2009. View Article : Google Scholar
|
|
106
|
Krediet TG, Wiertsema SP, Vossers MJ,
Hoeks SB, Fleer A, Ruven HJ and Rijkers GT: Toll-like receptor 2
polymorphism is associated with preterm birth. Pediatr Res.
62:474–476. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lorenz E, Hallman M, Marttila R, Haataja R
and Schwartz DA: Association between the Asp299Gly polymorphisms in
the Toll-like receptor 4 and premature births in the Finnish
population. Pediatr Res. 52:373–376. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Romero R, Xu Y, Plazyo O, Chaemsaithong P,
Chaiworapongsa T, Unkel R, Than NG, Chiang PJ, Dong Z, Xu Z, et al:
A role for the inflammasome in spontaneous labor at term. Am J
Reprod Immunol. 79:e124402018. View Article : Google Scholar
|
|
109
|
Lindström TM and Bennett PR: The role of
nuclear factor kappa B in human labour. Reproduction. 130:569–581.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
McCarthy R, Martin-Fairey C, Sojka DK,
Herzog ED, Jungheim ES, Stout MJ, Fay JC, Mahendroo M, Reese J,
Herington JL, et al: Mouse models of preterm birth: Suggested
assessment and reporting guidelines. Biol Reprod. 99:922–937.
2018.PubMed/NCBI
|
|
111
|
Zhu B, Tao Z, Edupuganti L, Serrano MG and
Buck GA: Roles of the microbiota of the female reproductive tract
in gynecological and reproductive health. Microbiol Mol Biol Rev.
86:e00181212022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Yudin MH, Landers DV, Meyn L and Hillier
SL: Clinical and cervical cytokine response to treatment with oral
or vaginal metronidazole for bacterial vaginosis during pregnancy:
A randomized trial. Obstet Gynecol. 102:527–534. 2003.PubMed/NCBI
|
|
113
|
Soto E, Romero R, Richani K, Yoon BH,
Chaiworapongsa T, Vaisbuch E, Mittal P, Erez O, Gotsch F, Mazor M
and Kusanovic JP: Evidence for complement activation in the
amniotic fluid of women with spontaneous preterm labor and
intra-amniotic infection. J Matern Fetal Neonatal Med. 22:983–992.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Romero R and Tartakovsky B: The natural
interleukin-1 receptor antagonist prevents interleukin-1-induced
preterm delivery in mice. Am J Obstet Gynecol. 167:1041–1045. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Nadeau-Vallée M, Quiniou C, Palacios J,
Hou X, Erfani A, Madaan A, Sanchez M, Leimert K, Boudreault A,
Duhamel F, et al: Novel noncompetitive IL-1 receptor-biased ligand
prevents infection- and inflammation-induced preterm birth. J
Immunol. 195:3402–3415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Robertson SA, Christiaens I, Dorian CL,
Zaragoza DB, Care AS, Banks AM and Olson DM: Interleukin-6 is an
essential determinant of on-time parturition in the mouse.
Endocrinology. 151:3996–4006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Di Simone N, Santamaria Ortiz A, Specchia
M, Tersigni C, Villa P, Gasbarrini A, Scambia G and D'Ippolito S:
Recent insights on the maternal microbiota: Impact on pregnancy
outcomes. Front Immunol. 11:5282022020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Chan D, Bennett PR, Lee YS, Kundu S, Teoh
TG, Adan M, Ahmed S, Brown RG, David AL, Lewis HV, et al:
Microbial-driven preterm labour involves crosstalk between the
innate and adaptive immune response. Nat Commun. 13:9752022.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Gonzalez JM, Franzke CW, Yang F, Romero R
and Girardi G: Complement activation triggers metalloproteinases
release inducing cervical remodeling and preterm birth in mice. Am
J Pathol. 179:838–849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Robertson SA, Skinner RJ and Care AS:
Essential role for IL-10 in resistance to
lipopolysaccharide-induced preterm labor in mice. J Immunol.
177:4888–4896. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Osman I, Young A, Ledingham MA, Thomson
AJ, Jordan F, Greer IA and Norman JE: Leukocyte density and
pro-inflammatory cytokine expression in human fetal membranes,
decidua, cervix and myometrium before and during labour at term.
Mol Hum Reprod. 9:41–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Rinaldi SF, Catalano RD, Wade J, Rossi AG
and Norman JE: Decidual neutrophil infiltration is not required for
preterm birth in a mouse model of infection-induced preterm labor.
J Immunol. 192:2315–2325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Mohd Zaki A, Hadingham A, Flaviani F,
Haque Y, Mi JD, Finucane D, Dalla Valle G, Mason AJ, Saqi M,
Gibbons DL and Tribe RM: Neutrophils dominate the cervical immune
cell population in pregnancy and their transcriptome correlates
with the microbial vaginal environment. Front Microbiol.
13:9044512022. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Cezar-de-Mello PFT, Ryan S and Fichorova
RN: The microRNA cargo of human vaginal extracellular vesicles
differentiates parasitic and pathobiont infections from
colonization by homeostatic bacteria. Microorganisms. 11:5512023.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zen M, Canova M, Campana C, Bettio S,
Nalotto L, Rampudda M, Ramonda R, Iaccarino L and Doria A: The
kaleidoscope of glucorticoid effects on immune system. Autoimmun
Rev. 10:305–310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Busillo JM, Azzam KM and Cidlowski JA:
Glucocorticoids sensitize the innate immune system through
regulation of the NLRP3 inflammasome. J Biol Chem. 286:38703–38713.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Hermoso MA, Matsuguchi T, Smoak K and
Cidlowski JA: Glucocorticoids and tumor necrosis factor alpha
cooperatively regulate toll-like receptor 2 gene expression. Mol
Cell Biol. 24:4743–4756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Baschant U and Tuckermann J: The role of
the glucocorticoid receptor in inflammation and immunity. J Steroid
Biochem Mol Biol. 120:69–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Franchimont D: Overview of the actions of
glucocorticoids on the immune response: A good model to
characterize new pathways of immunosuppression for new treatment
strategies. Ann NY Acad Sci. 1024:124–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Hearps AC, Tyssen D, Srbinovski D, Bayigga
L, Diaz DJD, Aldunate M, Cone RA, Gugasyan R, Anderson DJ and
Tachedjian G: Vaginal lactic acid elicits an anti-inflammatory
response from human cervicovaginal epithelial cells and inhibits
production of pro-inflammatory mediators associated with HIV
acquisition. Mucosal Immunol. 10:1480–1490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Delgado-Diaz DJ, Tyssen D, Hayward JA,
Gugasyan R, Hearps AC and Tachedjian G: Distinct immune responses
elicited from cervicovaginal epithelial cells by lactic acid and
short chain fatty acids associated with optimal and non-optimal
vaginal microbiota. Front Cell Infect Microbiol. 9:4462020.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Galdeano CM and Perdigón G: The probiotic
bacterium Lactobacillus casei induces activation of the gut mucosal
immune system through innate immunity. Clin Vaccine Immunol.
13:219–226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Rocha-Ramírez LM, Pérez-Solano RA,
Castañón-Alonso SL, Moreno Guerrero SS, Ramírez Pacheco A, García
Garibay M and Eslava C: Probiotic lactobacillus strains stimulate
the inflammatory response and activate human macrophages. J Immunol
Res. 2017:46074912017. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Anton L, Sierra LJ, DeVine A, Barila G,
Heiser L, Brown AG and Elovitz MA: Common cervicovaginal microbial
supernatants alter cervical epithelial function: Mechanisms by
which lactobacillus crispatus contributes to cervical health. Front
Microbiol. 9:21812018. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Dizzell S, Nazli A, Reid G and Kaushic C:
Protective effect of probiotic bacteria and estrogen in preventing
HIV-1-mediated impairment of epithelial barrier integrity in female
genital tract. Cells. 8:11202019. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Qi W, Li H, Wang C, Li H, Zhang B, Dong M,
Fan A, Han C and Xue F: Recent advances in presentation, diagnosis
and treatment for mixed vaginitis. Front Cell Infect Microbiol.
11:7597952021. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Dong M, Dong Y, Bai J, Li H, Ma X, Li B,
Wang C, Li H, Qi W, Wang Y, et al: Interactions between microbiota
and cervical epithelial, immune, and mucus barrier. Front Cell
Infect Microbiol. 13:11245912023. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Schönfeld P and Wojtczak L: Short- and
medium-chain fatty acids in energy metabolism: The cellular
perspective. J Lipid Res. 57:943–954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Aldunate M, Srbinovski D, Hearps AC,
Latham CF, Ramsland PA, Gugasyan R, Cone RA and Tachedjian G:
Antimicrobial and immune modulatory effects of lactic acid and
short chain fatty acids produced by vaginal microbiota associated
with eubiosis and bacterial vaginosis. Front Physiol. 6:1642015.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Amabebe E and Anumba DOC: The vaginal
microenvironment: The physiologic role of lactobacilli. Front Med
(Lausanne). 5:1812018. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Beghini J, Giraldo PC, Linhares IM, Ledger
WJ and Witkin SS: Neutrophil gelatinase-associated lipocalin
concentration in vaginal fluid: relation to bacterial vaginosis and
vulvovaginal candidiasis. Reprod Sci. 22:964–968. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Stafford GP, Parker JL, Amabebe E, Kistler
J, Reynolds S, Stern V, Paley M and Anumba DOC: spontaneous preterm
birth is associated with differential expression of vaginal
metabolites by lactobacilli-dominated microflora. Front Physiol.
8:6152017. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Amabebe E and Anumba DOC: A combination of
cervicovaginal fluid glutamate, acetate and D-Lactate identified
asymptomatic low-risk women destined to deliver preterm: A
prospective cohort study. Reprod Sci. 29:915–922. 2022. View Article : Google Scholar
|
|
144
|
Ghartey J, Bastek JA, Brown AG, Anglim L
and Elovitz MA: Women with preterm birth have a distinct
cervicovaginal metabolome. Am J Obstet Gynecol. 212:776.e1–776.e12.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Srinivasan S, Morgan MT, Fiedler TL,
Djukovic D, Hoffman NG, Raftery D, Marrazzo JM and Fredricks DN:
Metabolic signatures of bacterial vaginosis. mBio. 6:e002042015.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Menon R, Jones J, Gunst PR, Kacerovsky M,
Fortunato SJ, Saade GR and Basraon S: Amniotic fluid metabolomic
analysis in spontaneous preterm birth. Reprod Sci. 21:791–803.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Lizewska B, Teul J, Kuc P, Lemancewicz A,
Charkiewicz K, Goscik J, Kacerovsky M, Menon R, Miltyk W and
Laudanski P: Maternal plasma metabolomic profiles in spontaneous
preterm birth: Preliminary results. Mediators Inflamm.
2018:93628202018. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Smith DD and Rood KM: Intrahepatic
cholestasis of pregnancy. Clin Obstet Gynecol. 63:134–151. 2020.
View Article : Google Scholar
|
|
149
|
Tuckey RC: Progesterone synthesis by the
human placenta. Placenta. 26:273–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wilks M, Wiggins R, Whiley A, Hennessy E,
Warwick S, Porter H, Corfield A and Millar M: Identification and
H(2) O(2) production of vaginal lactobacilli from pregnant women at
high risk of preterm birth and relation with outcome. J Clin
Microbiol. 42:713–717. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
O'Hanlon DE, Moench TR and Cone RA: In
vaginal fluid, bacteria associated with bacterial vaginosis can be
suppressed with lactic acid but not hydrogen peroxide. BMC Infect
Dis. 11:2002011. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Mitchell C, Fredricks D, Agnew K and Hitti
J: Hydrogen peroxide-producing lactobacilli are associated with
lower levels of vaginal interleukin-1β, independent of bacterial
vaginosis. Sex Transm Dis. 42:358–363. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hemmerling A, Harrison W, Schroeder A,
Park J, Korn A, Shiboski S, Foster-Rosales A and Cohen CR: Phase 2a
study assessing colonization efficiency, safety, and acceptability
of Lactobacillus crispatus CTV-05 in women with bacterial
vaginosis. Sex Transm Dis. 37:745–750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Mayer BT, Srinivasan S, Fiedler TL,
Marrazzo JM, Fredricks DN and Schiffer JT: Rapid and profound
shifts in the vaginal microbiota following antibiotic treatment for
bacterial vaginosis. J Infect Dis. 212:793–802. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Bayar E, MacIntyre DA, Sykes L, Mountain
K, Parks TP, Lee PP and Bennett PR: Safety, tolerability, and
acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in
pregnant women at high-risk of preterm birth. Benef Microbes.
14:45–56. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Tomusiak A, Strus M, Heczko PB, Adamski P,
Stefański G, Mikołajczyk-Cichońska A and Suda-Szczurek M: Efficacy
and safety of a vaginal medicinal product containing three strains
of probiotic bacteria: A multicenter, randomized, double-blind, and
placebo-controlled trial. Drug Des Devel Ther. 9:5345–5354. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Vasundhara D, Raju VN, Hemalatha R, Nagpal
R and Kumar M: Vaginal & gut microbiota diversity in pregnant
women with bacterial vaginosis & effect of oral probiotics: An
exploratory study. Indian J Med Res. 153:492–502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Reid G, Charbonneau D, Erb J, Kochanowski
B, Beuerman D, Poehner R and Bruce AW: Oral use of Lactobacillus
rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal
flora: Randomized, placebo-controlled trial in 64 healthy women.
FEMS Immunol Med Microbiol. 35:131–134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Ho M, Chang YY, Chang WC, Lin HC, Wang MH,
Lin WC and Chiu TH: Oral Lactobacillus rhamnosus GR-1 and
Lactobacillus reuteri RC-14 to reduce Group B Streptococcus
colonization in pregnant women: A randomized controlled trial.
Taiwan J Obstet Gynecol. 55:515–518. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Anukam KC, Osazuwa E, Osemene GI,
Ehigiagbe F, Bruce AW and Reid G: Clinical study comparing
probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal
gel to treat symptomatic bacterial vaginosis. Microbes Infect.
8:2772–2776. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Hemalatha R, Mastromarino P, Ramalaxmi BA,
Balakrishna NV and Sesikeran B: Effectiveness of vaginal tablets
containing lactobacilli versus pH tablets on vaginal health and
inflammatory cytokines: A randomized, double-blind study. Eur J
Clin Microbiol Infect Dis. 31:3097–3105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Husain S, Allotey J, Drymoussi Z, Wilks M,
Fernandez-Felix BM, Whiley A, Dodds J, Thangaratinam S, McCourt C,
Prosdocimi EM, et al: Effects of oral probiotic supplements on
vaginal microbiota during pregnancy: A randomised, double-blind,
placebo-controlled trial with microbiome analysis. BJOG.
127:275–284. 2020. View Article : Google Scholar
|
|
163
|
Gille C, Böer B, Marschal M, Urschitz MS,
Heinecke V, Hund V, Speidel S, Tarnow I, Mylonas I, Franz A, et al:
Effect of probiotics on vaginal health in pregnancy. EFFPRO, a
randomized controlled trial. Am J Obstet Gynecol.
215:608.e1–608.e7. 2016. View Article : Google Scholar
|
|
164
|
Govinden G, Parker JL, Naylor KL, Frey AM,
Anumba DOC and Stafford GP: Inhibition of sialidase activity and
cellular invasion by the bacterial vaginosis pathogen Gardnerella
vaginalis. Arch Microbiol. 200:1129–1133. 2018. View Article : Google Scholar : PubMed/NCBI
|
